Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,246 | -6,516 | -4,095 | -2,111 | -4,899 |
| Depreciation Amortization | 1,130 | 658 | 348 | 147 | 97 |
| Accounts receivable | -93 | 405 | 64 | 117 | -155 |
| Other Working Capital | 1,688 | 1,468 | 514 | 392 | 21 |
| Other Operating Activity | 2,034 | 1,505 | 1,808 | 1,064 | 882 |
| Operating Cash Flow | $-4,487 | $-2,480 | $-1,361 | $-391 | $-4,054 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -4,290 | -1,600 | N/A | N/A | 2,769 |
| PPE Investments | -161 | -94 | -94 | -94 | -108 |
| Purchase Of Investment | 1 | 1 | 7 | 9 | -5 |
| Investing Cash Flow | $-4,450 | $-1,693 | $-87 | $-85 | $2,656 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,285 | 10,239 | 9,873 | N/A | 3,584 |
| Other Financing Activity | -600 | -600 | -600 | 0 | 0 |
| Financing Cash Flow | $9,685 | $9,639 | $9,273 | $N/A | $3,584 |
| Beginning Cash Position | 3,503 | 3,503 | 3,503 | 3,503 | 1,317 |
| End Cash Position | 4,251 | 8,969 | 11,328 | 3,027 | 3,503 |
| Net Cash Flow | $748 | $5,466 | $7,825 | $-476 | $2,186 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,487 | -2,480 | -1,361 | -391 | -4,054 |
| Capital Expenditure | -161 | -94 | -94 | -94 | -108 |
| Free Cash Flow | -4,648 | -2,574 | -1,455 | -485 | -4,162 |